Kalif Eliyahu Sharon
Insider CIK 1798443 · TEVA EVP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-06-11 | 2026-06-16 | 106,563 | $34.10 | $3.63M | 65,621 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-05-14 | 2026-05-18 | 153,251 | $35.61 | $5.46M | 172,184 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-05 | 2026-03-09 | 19,916 | — | $0 | 59,748 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-05 | 2026-03-09 | 19,916 | — | $0 | 325,435 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 33,512 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 23,251 | — | $0 | 46,503 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-03-04 | 2026-03-06 | 53,175 | — | $0 | 53,175 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 33,512 | — | $0 | 282,268 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 23,251 | — | $0 | 305,519 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 141,478 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 49,800 | — | $0 | 49,802 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 49,800 | — | $0 | 107,278 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 141,478 | — | $0 | 248,756 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-02-26 | 2026-03-02 | 345,810 | $33.64 | $11.63M | 57,478 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-01-27 | 2026-01-29 | 141,478 | — | $0 | 141,478 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-06-12 | 2025-06-16 | 55,775 | $17.08 | $952.6K | 403,288 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-03-05 | 2025-03-07 | 79,664 | — | $0 | 79,664 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-05 | 2025-03-07 | 21,390 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-05 | 2025-03-07 | 21,390 | — | $0 | 459,063 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 23,251 | — | $0 | 69,754 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 33,512 | — | $0 | 33,512 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 183,169 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 33,512 | — | $0 | 231,253 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 23,251 | — | $0 | 254,504 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 183,169 | — | $0 | 437,673 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-03 | 2025-03-04 | 49,800 | — | $0 | 99,602 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-03 | 2025-03-04 | 49,800 | — | $0 | 197,741 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-02-28 | 2025-03-04 | 55,750 | $16.21 | $903.7K | 147,941 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-01-28 | 2025-01-30 | 183,169 | — | $0 | 183,169 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-03-06 | 2024-03-07 | 77,550 | $13.52 | $1.05M | 203,691 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-05 | 2024-03-07 | 21,387 | — | $0 | 21,390 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-05 | 2024-03-07 | 52,320 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-05 | 2024-03-07 | 52,320 | — | $0 | 259,854 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-05 | 2024-03-07 | 21,387 | — | $0 | 281,241 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-04 | 2024-03-05 | 33,512 | — | $0 | 207,534 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-03-04 | 2024-03-05 | 93,005 | — | $0 | 93,005 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-04 | 2024-03-05 | 33,512 | — | $0 | 207,534 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-03 | 2024-03-05 | 49,800 | — | $0 | 174,022 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-03 | 2024-03-05 | 49,800 | — | $0 | 174,022 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-02-28 | 2024-03-01 | 18,430 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-02-28 | 2024-03-01 | 18,430 | — | $0 | 124,222 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-02-13 | 2024-02-15 | 6,630 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-02-13 | 2024-02-15 | 6,630 | — | $0 | 105,792 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-01-30 | 2024-02-01 | 52,320 | — | $0 | 52,320 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-08-07 | 2023-08-09 | 35,125 | $9.73 | $341.8K | 99,162 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-05 | 2023-03-07 | 21,387 | — | $0 | 42,777 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-05 | 2023-03-07 | 21,387 | — | $0 | 134,287 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-04 | 2023-03-07 | 33,512 | — | $0 | 100,536 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-04 | 2023-03-07 | 33,512 | — | $0 | 112,900 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-03-03 | 2023-03-07 | 199,202 | — | $0 | 199,202 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-28 | 2023-03-02 | 18,430 | — | $0 | 18,430 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-28 | 2023-03-02 | 44,953 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-28 | 2023-03-02 | 44,953 | — | $0 | 79,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-28 | 2023-03-02 | 18,430 | — | $0 | 34,435 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-13 | 2023-02-15 | 6,629 | — | $0 | 6,630 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-13 | 2023-02-15 | 6,629 | — | $0 | 16,005 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-02-07 | 2023-02-09 | 44,953 | — | $0 | 44,953 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-08-22 | 2022-08-24 | 55,500 | $10.07 | $558.9K | 9,376 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-05 | 2022-03-08 | 21,387 | — | $0 | 64,164 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-05 | 2022-03-08 | 21,387 | — | $0 | 64,876 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-03-04 | 2022-03-08 | 134,048 | — | $0 | 134,048 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-28 | 2022-03-02 | 18,430 | — | $0 | 36,860 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-28 | 2022-03-02 | 18,430 | — | $0 | 43,489 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-13 | 2022-02-15 | 6,629 | — | $0 | 13,259 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-13 | 2022-02-15 | 6,629 | — | $0 | 25,059 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-03-05 | 2021-03-08 | 85,551 | — | $0 | 85,551 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-28 | 2021-03-02 | 18,430 | — | $0 | 55,290 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-28 | 2021-03-02 | 18,430 | — | $0 | 18,430 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-28 | 2020-03-03 | 73,720 | — | $0 | 73,720 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-13 | 2020-02-18 | 19,888 | — | $0 | 19,888 | SEC↗ |